FDA Adverse Event Malfunction Summary report: N

ONETOUCHPING GLUCOSEMGMTSYSTEM

MDR report key: 3001978 · Received March 13, 2013

Report

Report Number
2531779-2013-02663
Event Type
Malfunction
Date Received
March 13, 2013
Report Date
February 19, 2013
Manufacturer
ANIMAS CORPORATION
Product Code
LZG
PMA / PMN Number
K080639
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PUMP HAS NOT BEEN RETURNED TO ANIMAS. ANIMAS HAS CONDUCTED A REVIEW OF THE DEVICE HISTORY RECORD FOR THIS PUMP AND CONFIRMED THAT IT WAS OPERATING WITHIN REQUIRED SPECIFICATIONS AT THE TIME OF RELEASE. IF THE DEVICE IS RETURNED, AN EVALUATION SHALL BE COMPLETED AND A SUPPLEMENTAL REPORT WILL BE FILED. NO CONCLUSIONS CAN BE MADE AT THIS TIME.

Additional Manufacturer Narrative · 1

FOLLOW-UP # 1 DATE OF SUBMISSION 04/19/2013-DEVICE EVALUATION: THE PUMP HAS BEEN RETURNED AND EVALUATED BY PRODUCT ANALYSIS ON (B)(4) 2013 WITH THE FOLLOWING FINDINGS: A REVIEW OF THE BLACK BOX HISTORY REVEALED REBOOTS. NO DAMAGE WAS FOUND TO THE BATTERY COMPARTMENT OR BATTERY CAP. THE BATTERY CAP WAS FOUND TO BE WITHIN SPECIFICATIONS. THE PUMP WAS EXERCISED FOR 24 HOURS WITH NO ALARMS OR POWER ISSUES OCCURRING. THE PUMP COVER WAS REMOVED AND NO DAMAGE, EVIDENCE OF MOISTURE, OR INTERMITTENT CONNECTION WAS FOUND IN THE POWER CIRCUIT OR BATTERY FLEX. UNRELATED TO THE COMPLAINT, THE PUMP'S HISTORY SHOWED A TIME AND DATE RESET TO FACTORY DEFAULT. THE PUMP'S INTERNAL BATTERY WAS FOUND LEAKING.

Description of Event or Problem · 1

THE REPORTER CONTACTED ANIMAS ON (B)(6) 2013 REPORTING THAT THE PUMP WAS TURNING OFF AND ON. THE REPORTER CONFIRMED THAT THE BATTERY CAP WAS SECURE TO THE PUMP WITH NO DAMAGE TO THE BATTERY COMPARTMENT OR PUMP. THIS REPORT IS MADE BASED ON THE ALLEGATION OF THE PUMP POWER ISSUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
105164 ONETOUCHPING GLUCOSEMGMTSYSTEM INSULIN INFUSION PUMP LZG ANIMAS CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 18 YR